Wuhan Hiteck Biological Pharma Co.,Ltd (SHE:300683)
China flag China · Delayed Price · Currency is CNY
32.72
+2.58 (8.56%)
Feb 4, 2026, 3:04 PM CST

SHE:300683 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Jan '23 Jan '22 Dec '20
Cash & Equivalents
169.54419.15510.22748.48184.05460.82
Short-Term Investments
-4.560.3142.75491.39288.73
Trading Asset Securities
526.22449.69578.71144.04514.4250.39
Cash & Short-Term Investments
695.75873.41,0891,0351,190999.94
Cash Growth
-20.72%-19.81%5.21%-12.99%18.99%-14.91%
Accounts Receivable
309.35300.78254.58233.21264.48231.6
Other Receivables
3.9500-3.180.45
Receivables
313.3300.78254.58233.21270.15235.28
Inventory
85.39108.98117.41120.1871.6569.63
Other Current Assets
34.2923.1826.9855.4750.8823.44
Total Current Assets
1,1291,3061,4881,4441,5831,328
Property, Plant & Equipment
677.93729.69734.56654.23519.63348.63
Long-Term Investments
35.0916.5827.0888.8965.295
Goodwill
178.59263.59263.59302.15316.17316.45
Other Intangible Assets
235.29253.44276.8890.379095
Long-Term Deferred Tax Assets
127.75119.94109.4780.5971.6457.63
Long-Term Deferred Charges
30.8834.4931.962.622.392.61
Other Long-Term Assets
222.71212.5739.5143.8749.8732.96
Total Assets
2,6372,9372,9712,7072,6982,187
Accounts Payable
43.5264.3552.0858.0551.7250.6
Accrued Expenses
14.5979.1159.8646.5146.4237.49
Short-Term Debt
7.147.227.3230.0333.046.49
Current Portion of Long-Term Debt
-14.8314.667.313.21-
Current Portion of Leases
-5.124.80.71.87-
Current Income Taxes Payable
6.363.872.842.464.522.45
Current Unearned Revenue
53.0877.5411697.9966.3844.68
Other Current Liabilities
120.81111.2188.5841.6842.09225.59
Total Current Liabilities
245.49363.26346.15284.73249.25367.31
Long-Term Debt
-11.5226.3240.9248.17-
Long-Term Leases
4.065.3610.42.593.64-
Long-Term Unearned Revenue
84.2684.2530.4727.922.5921.94
Long-Term Deferred Tax Liabilities
13.3614.7416.4813.117.257.94
Other Long-Term Liabilities
45.9245.9245.922.4523.5664.43
Total Liabilities
393.09525.05475.73371.7354.46461.62
Common Stock
130.89130.89130.89122.1122.1103.36
Additional Paid-In Capital
1,8371,8371,8371,5571,557987.76
Retained Earnings
265.83423.98510.34631.16645.19617.54
Total Common Equity
2,2342,3922,4782,3102,3241,709
Minority Interest
10.2519.817.3724.7918.6516.29
Shareholders' Equity
2,2442,4122,4962,3352,3431,725
Total Liabilities & Equity
2,6372,9372,9712,7072,6982,187
Total Debt
11.1944.0563.581.5589.926.49
Net Cash (Debt)
684.56829.351,026953.731,100993.45
Net Cash Growth
-17.07%-19.14%7.55%-13.29%10.72%-15.46%
Net Cash Per Share
5.296.347.907.4810.349.53
Filing Date Shares Outstanding
130.89130.89130.89122.1122.1103.36
Total Common Shares Outstanding
130.89130.89130.89122.1122.1103.36
Working Capital
883.24943.071,1421,1591,333960.99
Book Value Per Share
17.0618.2718.9318.9219.0416.53
Tangible Book Value
1,8201,8751,9381,9181,9181,297
Tangible Book Value Per Share
13.9014.3214.8015.7115.7112.55
Buildings
-500.14500.38398.72350.14174.04
Machinery
-528.75480.61339.05291.83228.39
Construction In Progress
-11.022.99120.9934.2780.14
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.